Target intelligence / Profile preview

Solute carrier family 14 member 2 (SLC14A2)

Target
SLC14A2
Molecular classification
Transporter, Membrane protein
01

Overview

Solute carrier family 14 member 2 (SLC14A2) encodes a highly selective urea transporter protein primarily expressed in the inner medulla of the kidney, where it mediates rapid transepithelial urea transport across the inner medullary collecting duct[1][5]. SLC14A2 is essential for the urinary concentration mechanism by facilitating urea reabsorption and recycling; this supports the kidney’s ability to concentrate urine and maintain fluid balance[3][4][5]. The encoded protein belongs to the urea transporter family, specifically the UT-A subgroup. Multiple alternatively spliced variants exist, conferring tissue and functional diversity. SLC14A2 is also involved in the process of urea nitrogen salvaging, indirectly supporting nutritional balance and gut microbiota in some mammals[3]. Urea transporter activity can be selectively blocked by certain inhibitors, which has implications for urinary concentrating disorders and fluid-electrolyte pathologies. There are no major inherited diseases directly caused by SLC14A2 mutations in humans but its expression is sensitive to hormonal regulation and renal physiological state[3][5].

Other names
Urea transporter 2UT-A2HUT2UT2UTAUTRhUT-A6urea transporter, kidneyurea transporter 2solute carrier family 14 (urea transporter) member 2
02

Mechanism of action

Urea transporter inhibition—blocks renal urea reabsorption, increases diuresis

03

Biological functions

Urinary concentrationTransepithelial urea transportUrea nitrogen salvaging
04

Disease associations

Renal diseaseFluid/electrolyte imbalanceOther
05

Safety considerations

Disruption of transporter function may alter urine concentrationaffect water/electrolyte homeostasisno major safety liabilities reported in humans but clinical implications in renal impairment
06

Interacting drugs

Urea analogues (e.g., thiourea)

2 more in the full profile.

Beyond the preview

Go deeper on Solute carrier family 14 member 2 (SLC14A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 14 member 2 (SLC14A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call